Patent details

Basic Information

Publication number:

EP3381445

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181675679

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

AQUEOUS FORMULATION OF ANTIBODY STABLISED BY ANTIOXIDANTS FOR PARENTERAL ADMINISTRATION

French Title of Invention:

FORMULATION AQUEUSE D'ANTICORPS STABILISÉE PAR DES ANTIOXYDANTS POUR ADMINISTRATION PARENTÉRALE

German Title of Invention:

WÄSSRIGE ANTIKÖRPERFORMULIERUNG MIT STABILISIERUNG DURCH ANTIOXIDANTIEN ZUR PARENTERALEN VERABREICHUNG

SPC Number:

Dates

Filing date:

13/11/2008

Grant date:

25/10/2023

EP Publication Date:

03/10/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/10/2023

EP B1 Publication Date:

25/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/11/2023

Expiration date:

13/11/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/10/2023

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Inventor

1

Name:

LI, Tiansheng

Address:

United States (US)

2

Name:

KO, Jason

Address:

United States (US)

3

Name:

SLOEY, Christopher, James

Address:

United States (US)

Priority

Priority Number:

988354 P

Priority Date:

15/11/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 38/18; A61K 38/19; A61K 39/395;

Publication

European Patent Bulletin

Issue number:

202343

Publication date:

25/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages